ELICA 0.1% CREAM 30G

Indications

Approved Uses

Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., atopic dermatitis/eczema and psoriasis).

Dosage & Administration

Dosing by Condition

Corticosteroid-responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin layer to affected areas once daily; reassess if no improvement within ~2 weeks; avoid routine occlusion and reserve for specialist direction in resistant plaques.

Initial Dose

Apply a thin film to the affected skin areas once daily.

Maintenance Dose

Apply a thin film to the affected skin areas once daily as needed for control. Therapy should be discontinued when control is achieved.

Maximum Dose

Apply a thin layer once daily; use the lowest amount for the shortest duration-reassess if no improvement within ~2 weeks; avoid prolonged continuous use especially on face/intertriginous areas and avoid large-area/occlusive use.

Side Effects

Common Side Effects

Common local effects: burning/stinging/tingling, pruritus, irritation/dryness/erythema; less common but clinically important with prolonged use: skin atrophy, striae, telangiectasia, hypopigmentation, folliculitis/acneiform eruptions, and secondary infection/contact dermatitis.

Side Effect Frequency

Common: application-site burning/stinging, pruritus, irritation/dryness; Uncommon: folliculitis, acneiform eruption, hypopigmentation, hypertrichosis, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, telangiectasia, miliaria; Rare: HPA-axis suppression/Cushingoid effects, hyperglycemia (risk increases with high dose, large area, occlusion, prolonged use, pediatrics).

Safety & Warnings

Warnings & Precautions

Avoid eyes/mucosa and periocular use; avoid occlusion unless directed; do not use on untreated infections-treat infection appropriately and stop if not controlled; use caution/limit duration on face, groin, axillae and in children due to higher absorption; avoid use for diaper rash; discontinue if irritation/sensitization occurs and reassess if no response within ~2 weeks.

Driving Warning

Safe

Drug Interactions

Food Interaction

No clinically relevant food interactions (not applicable for topical administration).

Special Populations

Elderly

Standard adult dosing; use with caution as elderly skin is more susceptible to atrophy and striae

Storage & Patient Advice

Patient Counseling

Apply a thin layer to affected skin once daily as prescribed; avoid eyes/mucosa; do not use on face/groin/axillae or under occlusion unless directed; do not use on infected skin unless treated; use the smallest amount for the shortest duration and seek review if not improving within ~2 weeks; avoid use for diaper rash; do not share (prescription-only).

Monitoring Requirements

Monitor clinical response and local adverse effects (atrophy, striae, telangiectasia, dermatitis, infection); consider HPA-axis suppression monitoring if used long-term, on large surface areas, under occlusion, in children, or on thin-skin areas; reassess need regularly.

Pharmacology

Mechanism of Action

Synthetic glucocorticoid that binds intracellular glucocorticoid receptors to alter gene transcription, inducing lipocortins that inhibit phospholipase A2 and reducing prostaglandin/leukotriene and cytokine-mediated inflammation, producing anti-inflammatory, antipruritic, and vasoconstrictive effects.

Duration of Effect

Approximately 24 hours per application (supports once-daily dosing).

Bioavailability

Minimal systemic absorption from intact skin (about 0.4-0.7%); absorption increases with inflammation, large surface area, prolonged use, occlusion, or thin-skin areas.

Product Information

Available Dosage Forms

Cream (this product per verified API data); mometasone furoate is also commonly available in other markets as ointment and lotion/solution (including scalp solution), but availability is product/market specific.

Composition per Dose

Each gram of cream: 1 mg mometasone furoate (0.1%) in a cream base

Skin Condition

Eczema, Psoriasis, Dermatitis

Steroid Potency

Potent

Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 22-07-2026